Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Ocugen Inc/

Recent news which mentions Ocugen Inc/

Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
Tickers INNO
Tags NRX Pharmaceuticals Inc/ Ocugen Inc/ Baudax Bio Inc/
From Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
Tickers INNO
Tags Inno Proscia Ocugen Inc/
From Business Journals
Lab Notes: Wedgewood Pharmacy acquires Colorado lab; Aprea Therapeutics raises $5.5M
Tickers INNO
Tags Strata Skin Sciences Inc/ Biotech Insurance
From Business Journals
Lab Notes: Drexel and Bancroft team up to advance autism research; AmerisourceBergen forms new partnership
Tickers INNO
Tags Pharmaceuticals AmerisourceBergen Corporation Medical Devices
From Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
Tickers INNO
Tags John J/ Jacobs Tela Bio Inc/ Jeffrey Dayno
From Business Journals
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
Tickers INNO
Tags Insurance Jolly Mazumdar Biotech
From Business Journals
Lab Notes: Cabaletta signs licensing deal for up to $162M; merger unites life sciences tech providers
Tickers INNO
Tags Zixuan Wang Inno Steven Nichtberger
From Business Journals
Lab Notes: Integral Molecular has first submission for new FDA pilot program; Jefferson ALS program expanding
Tickers INNO
Tags Ocugen Inc/ Robert J/ Hopkins Inno
From Business Journals
Ocugen's efforts to bring Covid-19 vaccine Covaxin to U.S. boosted by positive study results in children
Tags Coronavirus Biotech Health Care
From Business Journals
Lab Notes: Endo gets U.S. rights to potential knee pain drug; Optinose stock climbs after positive study results
Tickers INNO
Tags Biotech Insurance OptiNose Inc/
From Business Journals
Ocugen gets rights to Mexico in expanded Covaxin deal with Bharat Biotech
Tags Marcelo Ebrard Pharmaceuticals Ocugen Inc/
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
Tags Coronavirus Insurance Health Care
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
Tickers INNO
Tags Christopher J/ Burns Insurance John Lee
From Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
Tickers INNO
Tags David Enloe Ocugen Inc/ Windtree Therapeutics, Inc/
From Business Journals
Ocugen's stock plummets after FDA rejects emergency use bid for Covid vaccine
Tags Coronavirus Insurance Biotech
From Business Journals
Ocugen expects $53.5M from stock sale amid efforts to bring Covaxin to the U.S.
Tags Ocugen Inc/ Pharmaceuticals Coronavirus
From Business Journals
Ocugen signs letter of intent to buy Canadian pharmaceutical manufacturing plant
Tags Ocugen Inc/ Pharmaceuticals Coronavirus
From Business Journals
Lab Notes: Strata Skin Sciences makes acquisition; Cabaletta Bio promotes 2 executives
Tickers INNO
Tags Tom Tillett Health Care NexGel
From Business Journals
Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA
Tickers INNO
Tags Michael Mitchell Roundup Pharmaceuticals
From Business Journals
FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
Tags Pharmaceuticals Ocugen Inc/ Coronavirus
From Business Journals
Ocugen applies for emergency FDA authorization for use of its Covid-19 vaccine in children
Tags Pharmaceuticals Ocugen Inc/ Ocugen
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags Context Therapeutics Shankar Musunuri Insurance
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.